港股午评:恒科指大涨6.81% 恒指收复18000点 科技股集体走强
格隆汇11月15日丨港股上午盘三大指数呈单边上涨行情,恒生科技指数一马当先,午间大幅收涨6.81%,恒指、国指分别涨3.62%和4.27%,恒指重上18000点大关。盘面上,大型科技股集体拉升上扬,快手涨约13%,阿里巴巴涨超10%,腾讯涨超9%,美团、百度、京东皆大涨;昨日大涨的内房股与物管股继续上涨,但个别股票下跌明显,昨日一度飙涨50%的碧桂园跌超8%;短视频概念股涨势最佳,澳门新赌牌主须投资逾千亿澳元,濠赌股拉升明显,餐饮股、手游股、苹果概念股、汽车股等全线走强。另一方面,近期活跃的药品类股高开低走,开拓药业、白云山等纷纷回调。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.